CAS 1803084-79-8

Repaglinide Related Compound C ((S)-2-Ethoxy-4-[2-[[2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]amino]-2-oxoethyl] benzoic acid)

CAS: 1803084-79-8

Compounds containing an unfused pyridine ring in the structure, nesoi

Formel: C₃₀H₃₄N₂O₄

Farbe und Form: White Powder

Molekulargewicht: 486.25186

Ref: 45-1600846

Benzoic acid, 2-ethoxy-4-[2-oxo-2-[[(1S)-2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]amino]ethyl]-

CAS: 1803084-79-8

Formel: C₃₀H₃₄N₂O₄

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 486.6020

Ref: IN-DA01FPKT

Repaglinide USP Related Compound C

CAS: 1803084-79-8

Formel: C₃₀H₃₄N₂O₄

Molekulargewicht: 486.61

Ref: 4Z-R-1127

(S)-2-Ethoxy-4-(2-oxo-2-((2-phenyl-1-(2-(piperidin-1-yl)phenyl)ethyl)amino)ethyl)benzoic acid

CAS: 1803084-79-8

(S)-2-Ethoxy-4-(2-oxo-2-((2-phenyl-1-(2-(piperidin-1-yl)phenyl)ethyl)amino)ethyl)benzoic acid

Reinheit: 98%

Molekulargewicht: 486.61g/mol

Ref: 54-OR1063076

Repaglinide C

CAS: 1803084-79-8

Repaglinide C is a medicinal compound that has been shown to be a potent inhibitor of human protein kinases. It has demonstrated anticancer activity in Chinese hamster ovary and human cancer cell lines, inducing apoptosis and inhibiting tumor growth. Repaglinide C is an analog of the kinase inhibitor staurosporine, which is known for its broad-spectrum activity against various kinases. Repaglinide C has been found to have a high potency against several kinases involved in cancer cell signaling pathways, making it a promising candidate for cancer therapy. This compound has also been detected in human urine samples, suggesting potential use as a biomarker for monitoring kinase inhibitor therapy.

Formel: C₃₀H₃₄N₂O₄

Reinheit: Min. 95%

Molekulargewicht: 486.6 g/mol

Ref: 3D-DXC08479

Repaglinide Impurity C

CAS: 1803084-79-8

Formel: C₃₀H₃₄N₂O₄

Molekulargewicht: 486.61

Ref: ST-EA-CP-R24010